Format

Send to

Choose Destination
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225.

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Author information

1
Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, The Netherlands.
2
Department of Gastroenterology, Kremlin Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
3
Department of Medicine, Dermatology Unit, Gustave Roussy Cancer Campus, Villejuif, France.
4
Department of Pathology, Aberdeen University Medical School & Aberdeen Royal Infirmary, Aberdeen, UK.
5
Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
6
Royal Marsden Hospital NHS Foundation Trust, London, UK.
7
Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital of Heidelberg, Heidelberg, Germany.
PMID:
28881921
DOI:
10.1093/annonc/mdx225
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center